Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 5,994
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
JAMES KAWUKI STEPHEN
ID: UNCST-2025-R019616
 ENERGY POVERTY, HOUSEHOLD HEALTH STATUS AND HEALTH EXPENDITURE: A STRATEGIC MANAGEMENT AND POLICY IMPLICATION IN UGANDA’S ENERGY AND HEALTH SECTORS
REFNo: SS4396ES

i. To examine the relationship between energy poverty and Household health expenditure. ii. To evaluate the relationship between energy poverty and Household health status, with specific attention the role of gender and energy usage behaviour. iii. To establish the relationship between Household health expenditure and Household health status. iv. To develop a strategic management model that incorporates affordability sensitivity and gender- responsive interventions to mitigate energy poverty and improve health outcomes.
Uganda 2025-09-30 14:40:12 2028-09-30 Social Science and Humanities Non-Clinical Trial Degree Award
Apolo Balyegisawa P
ID: UNCST-2025-R017645
 Evaluation of the XF 300 Flow Cytometer, CD4 easy count kit, CD4% easy count kit and CD4/CD8 easy count kit in Tests 1112 - Explorative External Method Comparison Study and 1149.2 - Clinical Performance Study
REFNo: HS6435ES

Test 1112 - Compare the results from the XF-300 Flow Cytometer and its reagent kits with the comparator device (FACSLyric) and reagent kits Test 1149.2 - Investigate the clinical performance of the XF-300 Flow Cytometer in combination with the three kits CD4, CD4% and CD4/CD8 easy count kit.
Uganda 2025-09-30 14:39:06 2028-09-30 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Daisy Aliwaru
ID: UNCST-2025-R018043
 University Management And Pedagogical Innovations In Education: A Comparative Study Of Public And Private Universities In Uganda
REFNo: SS4340ES

1. To analyse the university management structures and practices that support pedagogical innovations in education at Muni University and Uganda Christian University. 2. To examine the effect of resource allocation for pedagogical innovations in education at Muni University and Uganda Christian University. 3. To determine the effect of incentives on pedagogical innovations in education at Muni University and Uganda Christian University. 4. To examine the effect of academic freedom for pedagogical innovations in education at Muni University and Uganda Christian University.
Uganda 2025-09-30 14:36:34 2028-09-30 Social Science and Humanities Non-Clinical Trial Degree Award
Emmanuel  Arinaitwe
ID: UNCST-2021-R011754
 THE SPREAD OF ARTEMISININ RESISTANCE IN AFRICA(SPARTAN 3); A longitudinal study to determine the fitness of artemisinin resistant parasites among asymptomatic infections
REFNo: HS6215ES

To detect a difference in the duration of ΔPfK13 versus wildtype infections. In addition to infection duration and parasite half-life as main outcomes of interest, we will compare ΔPfK13 and wildtype infections in terms of: - gametocyte commitment and gametocyte production - gametocyte half-life,
 Uganda 2025-09-30 14:35:17 2028-09-30 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Helen Byakwaga
ID: UNCST-2019-R001168
 A Phase III/IV factorial randomised double-blind trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin/ezetimibe versus pitavastatin, in patients with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk (Optimising metabolic management on integrase-based antiretroviral therapy – the OPTIMAR Study)
REFNo: HS5819ES

To assess the impact of pitavastatin vs. rosuvastatin/ezetimibe from baseline to 48 weeks on: fasting lipids, cardiovascular disease risk assessment measures; inflammatory biomarkers; and safety and tolerability,To assess the impact of dapagliflozin vs. placebo from baseline to 48 weeks on: intermediate markers of cardiovascular disease risk; cardiovascular disease risk assessment measures; clinical consequences of increased body weight; and safety and tolerability of dapagliflozin,To assess the impact of pitavastatin vs. rosuvastatin/ezetimibe on LDL concentration change from baseline to week 24,To assess the impact of dapagliflozin vs. placebo on absolute weight change from baseline to week 24,The overall objective of the study is to examine the impact of dapagliflozin vs. placebo on metabolic parameters in PWH with high metabolic risk who are on INSTI-based ART.,
 Uganda 2025-09-30 14:11:23 2028-09-30 Medical and Health Sciences Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS